for the three-month periods ended on September 30, 2018 and 2017 Unit: Million Baht Profit and Loss Statement Consolidated Financial Statement Comparison of Haft-Yearly Separate Financial statement In
ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate
consumption expanded gradually, in line with the expansion of consumption expenditure on durable goods and greater consumer confidence, as well as improvements in farm income. Meanwhile, private investment
slower rate in March and reached its bottom in April (-8.1% YoY), it made a v-shape recovery with 18.0% growth in June, partly driven by additional supply of C-Vitt from capacity expansion. - While Q2’20
network expansion led to increasing cost of service 3.9%YoY and 3.4%QoQ; however, SG&A was well-managed and dropped -12%YoY and -8.8%QoQ, resulted in stabilized EBITDA with -0.9%YoY and +1.6%QoQ. Net profit
the previous year due to continue an increase of export and private consumption, as well as an expansion of private investment. In addition, there were supporting factors from domestic demand from the
Medical Business Plc., (CMR) amount Baht 854.83 million. comparing at the same period in 2016 representing 3.30% increase. Income from medical treatments in the separate financial went down 3.46% due to the
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the
Chiang Mai Ram Medical Business Pcl., (CMR) amount Baht 1,035.05 million. comparing at the same period in 2016 representing 11.98% increase. Income from medical treatments in the separate financial went up
million . Income from medical treatments in the separate financial went down 1.22% due to the increased in the number of out-patients to 1.09% but the number of in-patients decreased 10.68 %. The rental and